GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » EV-to-FCF

Shanghai Kehua Bio-engineering Co (SZSE:002022) EV-to-FCF : -5.31 (As of May. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai Kehua Bio-engineering Co's Enterprise Value is ¥2,720 Mil. Shanghai Kehua Bio-engineering Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-512 Mil. Therefore, Shanghai Kehua Bio-engineering Co's EV-to-FCF for today is -5.31.

The historical rank and industry rank for Shanghai Kehua Bio-engineering Co's EV-to-FCF or its related term are showing as below:

SZSE:002022' s EV-to-FCF Range Over the Past 10 Years
Min: -649.83   Med: 46.62   Max: 2237.86
Current: -5.7

During the past 13 years, the highest EV-to-FCF of Shanghai Kehua Bio-engineering Co was 2237.86. The lowest was -649.83. And the median was 46.62.

SZSE:002022's EV-to-FCF is ranked worse than
100% of 361 companies
in the Medical Devices & Instruments industry
Industry Median: 28.78 vs SZSE:002022: -5.70

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Shanghai Kehua Bio-engineering Co's stock price is ¥6.83. Shanghai Kehua Bio-engineering Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.618. Therefore, Shanghai Kehua Bio-engineering Co's PE Ratio for today is At Loss.


Shanghai Kehua Bio-engineering Co EV-to-FCF Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co EV-to-FCF Chart

Shanghai Kehua Bio-engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.83 6.92 8.26 2.78 -6.98

Shanghai Kehua Bio-engineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.49 5.04 -15.39 -6.98 -8.05

Competitive Comparison of Shanghai Kehua Bio-engineering Co's EV-to-FCF

For the Medical Devices subindustry, Shanghai Kehua Bio-engineering Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Kehua Bio-engineering Co's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Kehua Bio-engineering Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Kehua Bio-engineering Co's EV-to-FCF falls into.



Shanghai Kehua Bio-engineering Co EV-to-FCF Calculation

Shanghai Kehua Bio-engineering Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2720.137/-512.138
=-5.31

Shanghai Kehua Bio-engineering Co's current Enterprise Value is ¥2,720 Mil.
Shanghai Kehua Bio-engineering Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-512 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Kehua Bio-engineering Co  (SZSE:002022) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shanghai Kehua Bio-engineering Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.83/-0.618
=At Loss

Shanghai Kehua Bio-engineering Co's share price for today is ¥6.83.
Shanghai Kehua Bio-engineering Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.618.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shanghai Kehua Bio-engineering Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Kehua Bio-engineering Co (SZSE:002022) Business Description

Traded in Other Exchanges
N/A
Address
No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
Executives
Li Ming Executives
He Jian Wen Executives
Ji Yu Ming Supervisors
Li Ji Executives
Sha Li Wu Director
Wang Man Directors, executives
Tang Wei Guo Director

Shanghai Kehua Bio-engineering Co (SZSE:002022) Headlines

No Headlines